Limited spots remain for the ATN Innovation Summit.
Secure your spot and join 750+ industry executives on June 16 & 17 in NYC.
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
Functional fitness brand Pvolve is contributing to the increased strength training demand, longevity movement and GLP-1 boom all at once
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Signos wins FDA clearance for first OTC glucose monitor for weight management, combining Dexcom’s Stelo with AI-driven health insights.
Evolt is shifting the focus from weight loss to muscle mass in fitness and other related fields through new findings
At the ATN Innovation Summit, functional medicine pioneer Dr. Frank Lipman shared his views on the fast-growing field of longevity science.
WeightWatchers relists on Nasdaq and expands into menopause care as it deepens its focus on medical-grade weight management.
With a pharma giant in its corner, WeightWatchers is mounting a comeback, relying on FDA-approved GLP-1 medications.
Syntis Bio has raised $38M to advance its injectable-free, once-daily pill that mimics gastric bypass surgery.
Sign Up to Our Newsletter
